Literature DB >> 16710369

Immunology: Toll-like receptors and antibody responses.

D Nemazee1, A Gavin, K Hoebe, B Beutler.   

Abstract

Microbial components, such as lipopolysaccharides, augment immune responses by activating Toll-like receptors (TLRs). Some have interpreted this to mean that TLR signalling might not only help to initiate the adaptive immune response, but may also be required for it. The expanded view is shared by Pasare and Medzhitov, who conclude from an analysis of mice deficient in MyD88 (a TLR-signalling adaptor protein) that the generation of T-dependent antigen-specific antibody responses requires activation of TLRs in B cells. However, we show here that robust antibody responses can be elicited even in the absence of TLR signals. This appreciable TLR-independence of immune responses should be taken into account in the rational design of immunogenic and toleragenic vaccines.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16710369      PMCID: PMC3787862          DOI: 10.1038/nature04875

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  3 in total

1.  Decoding the patterns of self and nonself by the innate immune system.

Authors:  Ruslan Medzhitov; Charles A Janeway
Journal:  Science       Date:  2002-04-12       Impact factor: 47.728

2.  Control of B-cell responses by Toll-like receptors.

Authors:  Chandrashekhar Pasare; Ruslan Medzhitov
Journal:  Nature       Date:  2005-11-17       Impact factor: 49.962

3.  Identification of Lps2 as a key transducer of MyD88-independent TIR signalling.

Authors:  K Hoebe; X Du; P Georgel; E Janssen; K Tabeta; S O Kim; J Goode; P Lin; N Mann; S Mudd; K Crozat; S Sovath; J Han; B Beutler
Journal:  Nature       Date:  2003-07-20       Impact factor: 49.962

  3 in total
  33 in total

Review 1.  New insights into the enigma of immunoglobulin D.

Authors:  Kang Chen; Andrea Cerutti
Journal:  Immunol Rev       Date:  2010-09       Impact factor: 12.988

2.  Adjuvant-enhanced antibody responses in the absence of toll-like receptor signaling.

Authors:  Amanda L Gavin; Kasper Hoebe; Bao Duong; Takayuki Ota; Christopher Martin; Bruce Beutler; David Nemazee
Journal:  Science       Date:  2006-12-22       Impact factor: 47.728

Review 3.  Unleashing the therapeutic potential of NOD-like receptors.

Authors:  Kaoru Geddes; João G Magalhães; Stephen E Girardin
Journal:  Nat Rev Drug Discov       Date:  2009-06       Impact factor: 84.694

4.  Comparing pooled peptides with intact protein for accessing cross-presentation pathways for protective CD8+ and CD4+ T cells.

Authors:  Hongwei Zhang; Hai Hong; Demin Li; Shiwu Ma; Ying Di; Adam Stoten; Neil Haig; Katalin Di Gleria; Zhanru Yu; Xiao-Ning Xu; Andrew McMichael; Shisong Jiang
Journal:  J Biol Chem       Date:  2009-02-04       Impact factor: 5.157

5.  Immunostimulatory activity of haptenated proteins.

Authors:  Noah W Palm; Ruslan Medzhitov
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-02       Impact factor: 11.205

Review 6.  Toll-like receptors--sentries in the B-cell response.

Authors:  Isabelle Bekeredjian-Ding; Gaetan Jego
Journal:  Immunology       Date:  2009-11       Impact factor: 7.397

Review 7.  Toll-like receptors: lessons to learn from normal and malignant human B cells.

Authors:  David Chiron; Isabelle Bekeredjian-Ding; Catherine Pellat-Deceunynck; Régis Bataille; Gaëtan Jego
Journal:  Blood       Date:  2008-06-30       Impact factor: 22.113

Review 8.  Role of Wnt signaling pathways in type 2 diabetes mellitus.

Authors:  Jing Chen; Chong Ning; Jingjing Mu; Dongnan Li; Yan Ma; Xianjun Meng
Journal:  Mol Cell Biochem       Date:  2021-02-10       Impact factor: 3.396

Review 9.  Modulation of Immune Response Using Engineered Nanoparticle Surfaces.

Authors:  Daniel F Moyano; Yuanchang Liu; Dan Peer; Vincent M Rotello
Journal:  Small       Date:  2015-11-30       Impact factor: 13.281

10.  Host DNA released in response to aluminum adjuvant enhances MHC class II-mediated antigen presentation and prolongs CD4 T-cell interactions with dendritic cells.

Authors:  Amy S McKee; Matthew A Burchill; Michael W Munks; Lei Jin; John W Kappler; Rachel S Friedman; Jordan Jacobelli; Philippa Marrack
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-27       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.